Recombinant Hepatitis B vaccine (Saccharomyces cerevisiae

Recombinant Hepatitis B vaccine (Saccharomyces cerevisiae
Product Description

Recombinant Hepatitis B vaccine is a preparation made of purified hepatitis B surface antigen (HBsAg) expressed by the recombinant Saccharomyces cerevisiae. After purification of HBsAg, a quantity of aluminum adjuvant is added to make the vaccine. The vaccine is a milky-white suspension with stratified precipitate which can be dispersed by shaking. It contains no preservative.

Beijing Minhai Biotechnology Co., Ltd

  • CN
  • 2023
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Specifications
  • Details
    0.5 ml per single human dose containing 10 ug of HBsAg.

Beijing Minhai Biotechnology Co., Ltd

  • CN
  • 2023
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical

More Products from Beijing Minhai Biotechnology Co., Ltd (2)

  • 13-valent pneumococcal conjugate vaccine

    Product 13-valent pneumococcal conjugate vaccine

    Protects against infectious diseases caused by pneumococcal types 1,3,4,5,6A,6B,7F,9V,14,18C,19A,19F and 23F, including pneumonia, meningitis, otitis media, bacteremia.

  • Varicella Vaccine, Live

    Product Varicella Vaccine, Live

    It can stimulate the body to produce immunity against varicella-zoster virus, which is used to prevent varicella.